January 6, 2026

Copper’s price breakthrough signals market rebalancing ahead

Copper’s surge past $13,000 signals a shift in market fundamentals where tight supply and future-facing demand reshape long-term investor outlooks...

Oil prices climb as market watches for a slow return of Venezuelan supply

Oil prices climb as investors assess whether Venezuela could slowly re-enter a market already flush with supply...

Investors are returning to Europe’s broadest index

The STOXX 600 has passed 600 for the first time as investors rotate into stable earnings and real assets across Europe...

Sterling strength signals early positioning in European FX markets

Sterling’s early strength against the euro in 2026 hints at shifting expectations around European monetary policy, with global risk sentiment now driving currency markets more than domestic data...

Fidelity China Special Situations highlights improving long-term market outlook

Fidelity China Special Situations reported a strong November 2025 as easing US–China tensions and renewed optimism around AI and innovation supported Chinese equities...

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk...

Investors may be misreading the risks ahead

Ruffer’s latest outlook urges investors to step back from market optimism and prepare for a shift in conditions that few are pricing in...

Emerging market positioning draws fresh attention

Investor appetite for emerging markets is rising as AI shifts global tech exposure beyond the US...

Gold is becoming a core portfolio holding

Gold’s evolving role in portfolios reflects a deeper investor shift toward stability, strategic diversification, and anticipation of policy change...

Fidelity Asian Values shares rise 25.7% and outperforms index over 1 year

Over the 12 months to 30 November 2025, Fidelity Asian Values plc delivered a NAV return of 16.1%, outperforming its reference index which rose 11.8%...

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and..

Global investors begin rotating into China’s tech stocks as valuations diverge

Capital is rotating into Chinese tech stocks as investors seek alternatives to stretched US valuations...

Harrow, Inc. (HROW) Stock Analysis: Navigating a 28.88% Upside Potential Amidst Robust Revenue Growth

In the bustling world of healthcare investments, Harrow, Inc. (HROW), a prominent player in the specialty and generic drug manufacturing sector, is garnering significant attention. With its focus on ophthalmic..

agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a 39% Potential Upside

The healthcare industry often stands at the forefront of investor discussions due to its essential role in society and potential for innovation-driven growth. Among the intriguing players in this sector..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring a Potential 36.59% Upside in the Biotech Arena

With its roots firmly planted in the biotechnology industry, Viridian Therapeutics, Inc. (NASDAQ: VRDN) is making waves, particularly in the treatment of serious and rare diseases. As the company advances..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 24% Upside Potential Amidst Strong Buy Ratings

Investors keeping an eye on the healthcare sector, particularly the medical devices industry, might find Establishment Labs Holdings Inc (NASDAQ: ESTA) a compelling prospect. Headquartered in Alajuela, Costa Rica, this..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Healthcare Gem with 38.89% Upside Potential

ANI Pharmaceuticals, Inc. (ANIP) has positioned itself as a noteworthy player in the healthcare sector, particularly within the drug manufacturing space, focusing on both specialty and generic products. With its..

Innoviva, Inc. (INVA) Stock Report: Exploring a 62% Upside Potential

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector of the healthcare industry, is attracting attention from investors due to its impressive potential upside of 62.26%. With a..

Mesoblast Limited (MESO) Stock Report: Exploring a 91.36% Potential Upside

Investors looking for opportunities in the biotechnology sector might find Mesoblast Limited (NASDAQ: MESO) an intriguing prospect. As an Australian-based leader in regenerative medicine, Mesoblast is making strides with its..

Evolent Health, Inc. (EVH) Stock Analysis: Can a 155% Upside Propel This Healthcare Innovator?

Evolent Health, Inc. (NASDAQ: EVH), a key player in the health information services sector, has been on the radar of investors due to its innovative approach to healthcare management and..

Search

Funds

January 6, 2026

Copper’s price breakthrough signals market rebalancing ahead

Copper’s surge past $13,000 signals a shift in market fundamentals where tight supply and future-facing demand reshape long-term investor outlooks...

Oil prices climb as market watches for a slow return of Venezuelan supply

Oil prices climb as investors assess whether Venezuela could slowly re-enter a market already flush with supply...

Investors are returning to Europe’s broadest index

The STOXX 600 has passed 600 for the first time as investors rotate into stable earnings and real assets across Europe...

Sterling strength signals early positioning in European FX markets

Sterling’s early strength against the euro in 2026 hints at shifting expectations around European monetary policy, with global risk sentiment now driving currency markets more than domestic data...

Fidelity China Special Situations highlights improving long-term market outlook

Fidelity China Special Situations reported a strong November 2025 as easing US–China tensions and renewed optimism around AI and innovation supported Chinese equities...

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk...

Investors may be misreading the risks ahead

Ruffer’s latest outlook urges investors to step back from market optimism and prepare for a shift in conditions that few are pricing in...

Emerging market positioning draws fresh attention

Investor appetite for emerging markets is rising as AI shifts global tech exposure beyond the US...

Gold is becoming a core portfolio holding

Gold’s evolving role in portfolios reflects a deeper investor shift toward stability, strategic diversification, and anticipation of policy change...

Fidelity Asian Values shares rise 25.7% and outperforms index over 1 year

Over the 12 months to 30 November 2025, Fidelity Asian Values plc delivered a NAV return of 16.1%, outperforming its reference index which rose 11.8%...

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows...

Global investors begin rotating into China’s tech stocks as valuations diverge

Capital is rotating into Chinese tech stocks as investors seek alternatives to stretched US valuations...
Search

Funds

January 6, 2026

FTSE 100

Funds